MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
Clinical trial NCT00769483 · COMPLETED
Trial details
- NCT number
- NCT00769483
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-13
- Primary completion
- 2020-09-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.